An FDA official who recently resign is being sued by Aurinia Pharmaceuticals (AUPH) for allegedly soliciting a bribe and tanking its stock with false statements in a revenge campaign against a former colleague, Liz Essley Whyte of The Wall Street Journal reports. Dr. George Tidmarsh was hired in July to lead the agency’s drug division.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AUPH:
- Aurinia Pharmaceuticals (AUPH) Q3 Earnings Cheat Sheet
- Aurinia Pharmaceuticals Advances Voclosporin Study in Young Lupus Nephritis Patients
- Aurinia Pharmaceuticals Advances Lupus Nephritis Study in Young Patients
- Aurinia Pharmaceuticals to Present New LUPKYNIS Data at Key Conferences
- Aurinia ‘stands behind’ favorable benefit/risk profile of LUPKYNIS
